J. Anract

ORCID: 0009-0006-7580-1066
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Prostate Cancer Treatment and Research
  • Urologic and reproductive health conditions
  • Urinary Bladder and Prostate Research
  • Urological Disorders and Treatments
  • Urinary and Genital Oncology Studies
  • COVID-19 and healthcare impacts
  • Renal cell carcinoma treatment
  • Optical Coherence Tomography Applications
  • Photoacoustic and Ultrasonic Imaging
  • Trauma and Emergency Care Studies
  • Pediatric Urology and Nephrology Studies
  • MRI in cancer diagnosis
  • Pelvic floor disorders treatments
  • Hernia repair and management
  • Renal and related cancers
  • Hormonal Regulation and Hypertension
  • Receptor Mechanisms and Signaling
  • Climate Change and Health Impacts
  • Genetic and Kidney Cyst Diseases
  • Sexual function and dysfunction studies
  • Radiomics and Machine Learning in Medical Imaging
  • Connexins and lens biology
  • Patient Satisfaction in Healthcare

Hôpital Cochin
2016-2025

Université Paris Cité
2016-2025

Inserm
2019-2025

Assistance Publique – Hôpitaux de Paris
2016-2025

Institut Necker Enfants Malades
2019-2025

Délégation Paris 5
2017-2023

Centre National de la Recherche Scientifique
2023

Pitié-Salpêtrière Hospital
2020-2021

Onco-Urologie Prédictive
2021

Sorbonne Université
2020-2021

Benign prostatic hyperplasia (BPH) is a prevalent condition in ageing men, often resulting significant lower urinary tract symptoms (LUTS) that impact quality of life. For patients with huge prostate volumes (>150 mL), surgical management presents challenges. Traditionally, open simple prostatectomy (OSP) was the gold standard; however, minimally invasive approaches such as robotic-assisted (RASP) and endoscopic enucleation (EEP), especially holmium laser (HoLEP), offer similar or superior...

10.1016/j.fjurol.2025.102877 article EN cc-by Deleted Journal 2025-03-01

Objective To assess the feasibility, safety and precision of organ-based tracking (OBT)-fusion targeted focal microwave ablation (FMA), in patients with low to intermediate risk prostate cancer. Patients method Ten a visible index tumor Gleason score ≤3+4, largest diameter <20mm were included. Transrectal OBT-fusion FMA was performed using an 18G needle. Primary endpoint evidence complete overlap by zone necrosis on MRI 7 days after ablation. Urinary sexual function assessed IPSS, IIEF5...

10.1371/journal.pone.0252040 article EN cc-by PLoS ONE 2021-07-14

Prostate cancer is the third cause of cancer-related deaths in men. Its early and reliable diagnosis still a public health issue, generating many useless prostate biopsies. cells detected urine could be target powerful test but they are considered too rare. By using an approach targeting rare cells, we have analyzed from 45 patients with 43 healthy subjects under 50 y.o. We observed relevant number giant cancer. Giant named Polyploid Cancer Cells (PGCC), thought to involved tumorigenesis...

10.3390/cancers15133366 article EN Cancers 2023-06-27

Objectives: The purpose of this study was to investigate the impact neoadjuvant chemotherapy (NAC) on perioperative morbidity and oncological outcomes according type regimen administered patients with muscle-invasive bladder cancer (MIBC) who subsequently underwent radical cystectomy (RC). Methods: Data were collected retrospectively 40 urothelial carcinoma had at least two cycles NAC, followed by RC, from 2011 2015 our institution. evaluated NAC toxicity, complications, cancer-specific,...

10.3389/fsurg.2018.00058 article EN cc-by Frontiers in Surgery 2018-09-19
Coming Soon ...